Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Pasqal, a pioneer in neutral-atom quantum computing, has announced the composition of its Board of Directors following its business combination with Bleichroeder Acquisition Corp. II. The combined company’s shares will begin trading on Nasdaq under the ticker PSQL. The Board includes Nobel laureate Alain Aspect as chair and senior industry leaders,…
Founder Group Limited is implementing a 100-for-1 share consolidation effective September 1, 2026, aiming to regain compliance with Nasdaq marketplace listing rules and maintain its Nasdaq Capital Market listing. The share price adjustment will not affect shareholder ownership percentages, and fractional shares will be rounded up to whole shares. T…
IBEX Limited, a Nasdaq-listed global leader in outsourced business services and AI-powered customer experience solutions, announced it will release its fourth quarter and fiscal year 2026 financial results after market close on September 10, 2026. The company will hold a conference call and webcast to discuss results, recent developments, and busin…
Stifel Financial Corp. announced robust operating data for July 2026, showing record fee-based client assets of $240 billion, a 15% year-over-year increase, and total client assets rising 11%. The firm experienced solid growth in bank loans by 19% year-over-year and increased treasury deposits by 59% compared to the previous year. These results ref…
Alerus Financial Corporation announced a quarterly cash dividend increase of 4.76% to $0.22 per common share, payable October 9, 2026. Additionally, the company approved a new stock repurchase program authorizing up to 1.25 million shares, effective after completion or expiration of the prior program, expiring in August 2029. These actions reflect …
Capital City Bank Group, Inc., a financial holding company headquartered in Florida, announced a quarterly cash dividend of $0.27 per share, with an annualized dividend yield of 2.11%. The dividend is payable on September 22, 2026, to shareholders of record as of September 8, 2026. The company provides various banking and financial services primari…
IREN Limited announced its FY26 financial results, highlighting significant growth in AI Cloud Services revenue (8x increase), a new multi-year contract with a leading frontier AI lab, a largely sold-out 2026 capacity with $4bn contracted ARR, and expanded data center pipeline globally. The company executed capital-efficient GPU financings to suppo…
Root, Inc. announced a 15% average reduction in auto insurance premiums for its Florida customers, citing the positive impact of recent legal reforms that have stabilized the state's insurance market and lowered litigation-related costs. This move reflects significant cost savings which Root plans to pass on to more than 52,000 policyholders in Flo…
Outlook Therapeutics, a biopharmaceutical company, appointed Kevin Lundquist as CFO to lead the financial and operational infrastructure as it prepares for the U.S. commercial launch of its FDA-approved drug LYTENAVA™ for wet age-related macular degeneration. Lundquist brings over 20 years of experience in pharmaceutical finance and commercial oper…
Parsons Corporation has been awarded two new task orders under the National Nuclear Security Administration's Counter Nuclear Smuggling Systems Deployment contract. These awards cover design and deployment of counter-nuclear smuggling systems in 25 countries across the Middle East and Africa, enhancing Parsons' portfolio to seven task orders valued…
Resmed announced that its CEO Mick Farrell and CFO Aaron Bloomer will participate in the 24th Annual Morgan Stanley Global Healthcare Conference on September 15, 2026, presenting via webcast to discuss the company’s advances and business outlook. Resmed specializes in AI-powered digital health solutions and cloud-connected devices for home healthca…
LifeVantage Corporation announced its fourth fiscal quarter and full fiscal year 2026 financial results, revealing a significant decline in revenue, net income, and adjusted EBITDA compared to the prior year. The company attributes these decreases mainly to lower sales in the Americas and Asia/Pacific & Europe regions, impacted by macroeconomic pre…
First Watch Restaurant Group, Inc., a leading daytime dining chain serving breakfast, brunch, and lunch, announced its participation in two prominent investor conferences in September 2026: the Barclays 19th Annual Global Consumer Conference and Piper Sandler’s 5th Annual Growth Frontiers Conference. The company will host a live webcast fireside ch…
Applied Materials appoints Akash Palkhiwala, CFO and COO of Qualcomm, to its board of directors and Audit Committee, highlighting his extensive semiconductor finance and operational experience as a boost to the company's growth trajectory.
Zumiez Inc., a specialty retailer of apparel and accessories for young adults, will report its fiscal 2026 second quarter results on September 10, 2026. Following the release, the company will hold a conference call and webcast for investors and interested parties to discuss the financial performance and outlook. Zumiez operates 714 stores worldwid…
Pasqal Holding SA finalized its merger with Bleichroeder Acquisition Corp. II, becoming a publicly traded company on Nasdaq under ticker symbol PSQL. The transaction provides Pasqal with approximately $360 million in cash to advance deployment, commercial adoption, and development of its neutral-atom quantum computing technology toward fault-tolera…
Pulmonx Corporation, a Nasdaq-listed company specializing in minimally invasive treatments for severe lung disease, will have its management team participate in two major investor conferences in September 2026. The company's products, including the FDA-approved Zephyr® Endobronchial Valve, are recognized in global treatment guidelines for severe em…
Key Tronic Corporation announced its financial results for Q4 and fiscal year 2026. The company saw a 14% sequential increase in Q4 revenue driven by strong demand in Vietnam and the US, despite liquidity and supply chain constraints delaying shipments. Full-year revenue decreased due to reduced demand from legacy programs and geopolitical uncertai…
Heartflow, Inc., a Nasdaq-listed company leading in AI technology for coronary artery disease diagnosis, will participate in the Wells Fargo 21st Annual Healthcare Conference with a management fireside chat. The company underscores its clinical validation, extensive imaging database, and global compliance standards, reinforcing its role in transfor…
Asure Software, a U.S.-based provider of payroll and HR solutions, announced the honorees of its second annual Asure50 Awards recognizing 50 outstanding small and mid-sized businesses (SMBs) across North America. The award ceremony will feature industry leaders and provide insights into workforce trends, retention strategies, and AI adoption impact…
The E.W. Scripps Company has hired Jen Carfley, formerly of NBCUniversal, as head of small and medium business growth and direct response advertising. Carfley will develop enterprise-wide strategies to connect SMB advertisers with Scripps' premium video inventory across multiple platforms, including local, national, linear, and connected TV. She wi…
Roivant announced FDA approval of LISRAYA™ (brepocitinib), the first targeted oral therapy for adults with dermatomyositis (DM), a rare autoimmune disease. LISRAYA demonstrated robust efficacy in the largest DM clinical trial to date, improving muscle strength, skin symptoms, physical function, and reducing steroid dependence. The drug is now avail…
Priovant Therapeutics announced FDA approval of LISRAYA™ (brepocitinib), a first-in-class TYK2/JAK1 inhibitor, for the treatment of adults with dermatomyositis, a rare systemic autoimmune disease. The approval follows positive Phase 3 VALOR trial results demonstrating significant improvements in disease activity and steroid-sparing benefits. LISRAY…
MaxLinear (MXL) is printing growth that looks like a multi-year plan compressed into months: Q1 revenue and a bullish Q2 guide signal infrastructure wins with hyperscalers. At a $5.7B market cap the stock already reflects the rally, but upside to $110 is plausible if revenue keeps compounding and margins recover. This trade idea lays out entry, sto…
JATT III Acquisition Corp, a newly formed blank check company incorporated in the Cayman Islands, closed its initial public offering on August 27, 2026, raising $69 million by issuing 6.9 million ordinary shares at $10 each on NASDAQ under the ticker JTTT. The company aims to seek a business combination primarily in the healthcare sector, focusing …
